The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries

BACKGROUND: Advances in pharmaceuticals offer improved health outcomes for a wide range of illnesses, yet medicines are often inaccessible for many patients worldwide. One potential barrier to making medicines available to all is the cost of product registration, the fees for regulatory review and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Steven G., Yau, Brandon, Lumpkin, Murray M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557367/
https://www.ncbi.nlm.nih.gov/pubmed/28809931
http://dx.doi.org/10.1371/journal.pone.0182742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557367/
https://www.ncbi.nlm.nih.gov/pubmed/28809931
http://dx.doi.org/10.1371/journal.pone.0182742

Ejemplares similares